Editorial Commentary
Adjuvant treatment in resected biliary cancers: fluoropyrimidines on the spotlight
Translational Cancer Research
2024;
13
(9)
:4510-4513
.
(30 September 2024)
New insights into the impact of impaired epigenetic machinery on liver cancer malignant phenotype
Translational Cancer Research
2024;
13
(9)
:4514-4519
.
(30 September 2024)
Original Article
Telomere-related prognostic signature for survival assessments in lung adenocarcinoma
Translational Cancer Research
2024;
13
(9)
:4520-4533
.
(30 September 2024)
BUB1 as a novel marker for predicting the immunotherapy efficacy and prognosis of breast cancer
Translational Cancer Research
2024;
13
(9)
:4534-4554
.
(30 September 2024)
Comprehensive analysis of cuproptosis-related genes involved in prognosis and tumor microenvironment infiltration of colorectal cancer
Translational Cancer Research
2024;
13
(9)
:4555-4573
.
(30 September 2024)
A novel gene signature based on endoplasmic reticulum stress for predicting prognosis in hepatocellular carcinoma
Translational Cancer Research
2024;
13
(9)
:4574-4592
.
(30 September 2024)
Analysis of the mechanism of berberine against stomach carcinoma based on network pharmacology and experimental validation
Translational Cancer Research
2024;
13
(9)
:4593-4607
.
(30 September 2024)
A novel prognostic model based on telomere-related lncRNAs in gastric cancer
Translational Cancer Research
2024;
13
(9)
:4608-4624
.
(30 September 2024)
Preparation and anticancer activity of telomerase inhibitor TAT-LPTS39 polypeptide
Translational Cancer Research
2024;
13
(9)
:4625-4638
.
(30 September 2024)
Construction and verification of an innovative immune-related and hallmark gene sets prognostic model for bladder cancer
Translational Cancer Research
2024;
13
(9)
:4639-4653
.
(30 September 2024)
The probability of implantation metastasis after peripheral lung cancer biopsy
Translational Cancer Research
2024;
13
(9)
:4654-4658
.
(30 September 2024)
Development and validation of a clinical diagnostic model for surgical site infection after surgery in patients with gastric cancer
Translational Cancer Research
2024;
13
(9)
:4659-4670
.
(30 September 2024)
Mendelian randomization study on simvastatin and gastric cancer: exploring the therapeutic potential of statins in oncology
Translational Cancer Research
2024;
13
(9)
:4671-4677
.
(30 September 2024)
Development and validation of a nomogram to predict overall survival of gastroenteropancreatic neuroendocrine carcinoma: a SEER database analysis
Translational Cancer Research
2024;
13
(9)
:4678-4693
.
(30 September 2024)
Clinicopathological study of fractional exhaled nitric oxide dynamics and intratumoral inducible nitric oxide synthase expression in primary lung cancer patients
Translational Cancer Research
2024;
13
(9)
:4694-4701
.
(30 September 2024)
Causal relationship between circulating immune cells and gastric cancer: a bidirectional Mendelian randomization analysis using UK Biobank and FinnGen datasets
Translational Cancer Research
2024;
13
(9)
:4702-4713
.
(30 September 2024)
The m5C/m6A/m7G-related non-apoptotic regulatory cell death genes for the prediction of the prognosis and immune infiltration status in hepatocellular carcinoma
Translational Cancer Research
2024;
13
(9)
:4714-4735
.
(30 September 2024)
Expression and prognostic impact of VDAC3 in colorectal adenocarcinoma
Translational Cancer Research
2024;
13
(9)
:4736-4751
.
(30 September 2024)
Unveiling the role of KRAS in Chinese colorectal cancer patients: a positive influence on tumor mutational burden
Translational Cancer Research
2024;
13
(9)
:4752-4762
.
(30 September 2024)
Establishment of a nomogram for potential prediction of lung metastasis in patients with primary limb bone tumors: a study based on the SEER database
Translational Cancer Research
2024;
13
(9)
:4763-4774
.
(30 September 2024)
TiRNA-Gly-GCC-002 is associated with progression in patients with hepatocellular carcinoma
Translational Cancer Research
2024;
13
(9)
:4775-4785
.
(30 September 2024)
Construction and validation of senescence risk score signature as a novel biomarker in liver hepatocellular carcinoma: a bioinformatic analysis
Translational Cancer Research
2024;
13
(9)
:4786-4799
.
(30 September 2024)
Upregulation of miRNA-450b-5p targets ACTB to affect drug resistance and prognosis of ovarian cancer via the PI3K/Akt signaling pathway
Translational Cancer Research
2024;
13
(9)
:4800-4812
.
(30 September 2024)
Heterogeneity of tumor microenvironment cell groups in inflammatory and adenomatous polyposis coli mutant colorectal cancer based on single cell sequencing
Translational Cancer Research
2024;
13
(9)
:4813-4826
.
(30 September 2024)
Prognostic biomarkers based on GUF1, EFTUD2 and GSPT1 targets affecting migration of gastric cancer cells
Translational Cancer Research
2024;
13
(9)
:4827-4845
.
(30 September 2024)
Construction of a prognostic model with exosome biogenesis- and release-related genes and identification of RAB27B in immune infiltration of pancreatic cancer
Translational Cancer Research
2024;
13
(9)
:4846-4865
.
(30 September 2024)
RNA sequencing reveals transcriptomic changes in PC-12 cells following plasminogen activator, tissue type overexpression
Translational Cancer Research
2024;
13
(9)
:4866-4877
.
(30 September 2024)
Prognosis and progression of phagocytic regulatory factor-related gene combinations in clear cell renal cell carcinoma (ccRCC)
Translational Cancer Research
2024;
13
(9)
:4878-4895
.
(30 September 2024)
Tumor-derived exosomal miR-103a-3p promotes vascular permeability and proliferation by targeting ZO-1 and ACOX-1 in nasopharyngeal carcinoma
Translational Cancer Research
2024;
13
(9)
:4896-4912
.
(30 September 2024)
Long non-coding RNA LINC-PINT is associated with favorable prognosis in cancer patients: a systematic review and meta-analysis
Translational Cancer Research
2024;
13
(9)
:4913-4922
.
(30 September 2024)
The LINC00957/miR-17-5p axis regulates the cell cycle and migration in glioblastoma via the cuproptosis-related gene nephronectin
Translational Cancer Research
2024;
13
(9)
:4923-4937
.
(30 September 2024)
Unveiling the atlas of associations between 1,400 plasma metabolites and 24 tumors: Mendelian randomization analyses
Translational Cancer Research
2024;
13
(9)
:4938-4956
.
(30 September 2024)
Prognostic value of PLEKHA4 and its correlation with tumor-infiltrating immune cells in breast cancer: a comprehensive study based on bioinformatics and clinical analysis validation
Translational Cancer Research
2024;
13
(9)
:4957-4972
.
(30 September 2024)
Development and validation of a recurrence risk assessment model for high-grade bladder cancer based on TCGA and GEO
Translational Cancer Research
2024;
13
(9)
:4973-4984
.
(30 September 2024)
TGF-β signaling-related signature for predicting prognosis and therapeutic response in lower-grade glioma
Translational Cancer Research
2024;
13
(9)
:4985-5002
.
(30 September 2024)
Analysis of the role of POC1A in the development and progression of hepatocellular carcinoma
Translational Cancer Research
2024;
13
(9)
:5003-5020
.
(30 September 2024)
The role of IQCB1 in liver cancer: a bioinformatics analysis
Translational Cancer Research
2024;
13
(9)
:5021-5036
.
(30 September 2024)
The surgical, histopathological characteristics, and survival outcome of ovarian clear cell carcinoma: a retrospective case series sharing the experience of a tertiary cancer centre
Translational Cancer Research
2024;
13
(9)
:5037-5049
.
(30 September 2024)
Comparison of surgical margins and adjuvant therapy for head and neck cancer by hospital type
Translational Cancer Research
2024;
13
(9)
:5050-5063
.
(30 September 2024)
Disulfidptosis-related gene SLC7A11 predicts prognosis and indicates tumor immune infiltration in lung adenocarcinoma
Translational Cancer Research
2024;
13
(9)
:5064-5072
.
(30 September 2024)
TCF4 as a potential prognostic biomarker and an anticancer target in gastric cancer
Translational Cancer Research
2024;
13
(9)
:5073-5086
.
(30 September 2024)
Bioinformatics study of bortezomib resistance-related proteins and signaling pathways in mantle cell lymphoma
Translational Cancer Research
2024;
13
(9)
:5087-5096
.
(30 September 2024)
GLYAT suppresses liver cancer and clear cell renal cell carcinoma progression by downregulating ROCK1 expression
Translational Cancer Research
2024;
13
(9)
:5097-5111
.
(30 September 2024)
Review Article
Narrative review of research progress of RNA m5C methylation in head and neck malignancies
Translational Cancer Research
2024;
13
(9)
:5112-5122
.
(30 September 2024)
Strategies and influencing factors for the treatment of advanced non-small cell lung cancer based on epidermal growth factor receptor tyrosine kinase inhibitors: a narrative review
Translational Cancer Research
2024;
13
(9)
:5123-5140
.
(30 September 2024)
Case Report
A case report of robot-assisted radical nephrectomy and inferior vena cava thrombectomy in a patient with renal cell carcinoma after pembrolizumab and axitinib combination therapy
Translational Cancer Research
2024;
13
(9)
:5141-5148
.
(30 September 2024)
Visual impairment as the initial presentation in multiple myeloma: a case report and literature review
Translational Cancer Research
2024;
13
(9)
:5149-5156
.
(30 September 2024)
Erratum
Erratum to MicroRNA-106a suppresses prostate cancer proliferation, migration and invasion by targeting tumor-derived IL-8
Translational Cancer Research
2024;
13
(9)
:5157-5158
.
(30 September 2024)
Erratum to reduction of Hip2 suppresses gastric cancer cell proliferation, migration, invasion and tumorigenesis
Translational Cancer Research
2024;
13
(9)
:5159-5160
.
(30 September 2024)
Retraction
Retraction: WSB2 as a target of Hedgehog signaling promoted the malignantbiological behavior of Xuanwei lung cancer through regulating Wnt/β-catenin signaling
Translational Cancer Research
2024;
13
(9)
:5161
.
(30 September 2024)
